Area of research
Oncology · Obstetrics and Gynecology
Research interest
Research interests include Medicine, Internal medicine, Clinical endpoint, Tolerability, Response Evaluation Criteria in Solid Tumors, and Phases of clinical research.
A multicenter, open-label, single-arm, phase II trial to evaluate the efficacy and safety of geptanolimab (GB226) in the treatment of patients (pts) with programmed cell death ligand 1 (PD-L1)–positive recurrent or metastatic cervical cancer, for whom prior platinum-containing chemotherapy has failed.
Efficacy and Safety of the Anti–PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study